NOD2 and inflammatory bowel disease: Overall, the NOD2 and TLR families are central regulatory nodes in the innate immune response of IBD; in the future, the combination of specific receptor modulators, molecular targeting, and immune regulation is expected to achieve personalized treatment and precise inflammation control.